18:06 , Aug 31, 2018 |  BC Week In Review  |  Financial News

Longitude joins syndicate for women's health play KaNDy's £25M series C

KaNDy Therapeutics Ltd. (Stevenage, U.K.) raised £25 million ($31.9 million) in a series C round on Aug. 29. New investor Longitude Capital joined existing investors Advent Life Sciences, Fountain Healthcare Partners, Forbion Capital Partners and...
20:59 , Aug 29, 2018 |  BioCentury  |  Finance

Sweetening the pot

KaNDy Therapeutics Ltd. believes its first venture round as an independent company will fund development of a non-hormonal therapy for menopausal symptoms that will be ready for a Phase III trial by 2020. Longitude Capital...
06:00 , Aug 29, 2018 |  BC Extra  |  Financial News

Longitude joins syndicate for women's health play KaNDy's £25M series C

KaNDy Therapeutics Ltd. (Stevenage, U.K.) raised £25 million ($31.9 million) in a series C round. New investor Longitude Capital joined existing investors Advent Life Sciences, Fountain Healthcare Partners, Forbion Capital Partners and OrbiMed in the...
02:27 , May 25, 2018 |  BC Extra  |  Financial News

Anti-infectives play Iterum raises $80M in IPO

Iterum Therapeutics plc (NASDAQ:ITRM) raised $80 million late Thursday through the sale of 6.2 million shares at $13 in an IPO underwritten by Leerink, RBC Capital Markets, Guggenheim and Needham. The price values Iterum at...
21:15 , May 18, 2018 |  BioCentury  |  Finance

China comes to Europe

  The historically underfunded European biotech sector is in the early stages of tapping into a new stream of capital thanks to the explosion of biomedical innovation in China, which has spawned a wave of...
17:08 , Apr 6, 2018 |  BC Week In Review  |  Financial News

Macrolide raises $20M

Macrolide Pharmaceuticals Inc. (Watertown, Mass.) raised $20 million on April 2 in a venture round led by existing investors Advent Life Sciences, Gurnet Point Capital, Novartis Venture Fund, Roche Ventures and SR One. The antibiotic...
18:48 , Apr 2, 2018 |  BC Extra  |  Financial News

Antibiotic play Macrolide raises $20M, names Karande CEO

Macrolide Pharmaceuticals Inc. (Watertown, Mass.) raised $20 million on Monday in a venture round led by existing investors Advent Life Sciences, Gurnet Point Capital, Novartis Venture Fund, Roche Ventures and SR One. The antibiotic company...
15:02 , Dec 22, 2017 |  BC Week In Review  |  Financial News

Aura raises $30M series C

Aura Biosciences Inc. (Cambridge, Mass.) raised $30 million in a series C round led by new investors Lundbeckfonden Ventures and Arix Bioscience plc. Existing investors also participated, including Advent Life Sciences, Chiesi Ventures, Ysios Capital,...
07:01 , Dec 21, 2017 |  BC Extra  |  Financial News

Aura raises $30M series C

Aura Biosciences Inc. (Cambridge, Mass.) raised $30 million in a series C round led by new investors Lundbeckfonden Ventures and Arix Bioscience plc. Existing investors also participated, including Advent Life Sciences, Chiesi Ventures, Ysios Capital,...
22:53 , May 26, 2017 |  BioCentury  |  Finance

Europe’s bellwether challenge

A healthy biotech ecosystem comprises a continuum from big pharma and bellwether biotechs at the top to private newcos at the bottom, with a mixture of liquidity events -- predominantly M&A -- to reward investors....